MHRAโ€™s authority restored following Northern Ireland Brexit deal

February 28, 2023
Medical Communications

The Medicines and Healthcare products Regulatory Agency (MHRA) has been limited to approving medicines in Great Britain (England, Scotland and …

Rare and orphan disease expert Terebellum launches market access guide

February 28, 2023
Business Services

Terebellum, subsidiary of global specialty pharmacy and healthcare solutions organisation AscellaHealth, is launching a strategic guide to help manufacturers bring …

PureTech Founded Entity Sonde Health and Massachusetts General Hospital Selected for National Institute on Aging Study to Examine Use of Voice in Remote Detection and Monitoring of Mild Cognitive Impairment Including Frontotemporal Disorders (FTD)

February 27, 2023
Business Services

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (โ€œPureTechโ€ or the โ€œCompanyโ€), a clinical-stage biotherapeutics company, noted today that its Founded …

Almirall opens the doors of its R&D centre to the biotech ZeClinics

February 27, 2023
Business Services

BARCELONA, Spain. February 27th 2023 โ€“ Almirall, a global biopharmaceutical company focused on skin health, today announced an agreement with …

HUTCHMED Completes Patient Enrollment of Phase II Registration Trial of Amdizalisib in Follicular Lymphoma in China

February 27, 2023
Business Services

Hong Kong, Shanghai & Florham Park, NJ โ€” Monday, February 27, 2023: HUTCHMED (China) Limited (โ€œHUTCHMEDโ€) (Nasdaq/AIM:โ€‹HCM, HKEX:โ€‹13) today announces …

CN Bio extends microphysiological system portfolio with PhysioMimix Single-Organ Higher Throughput System

February 27, 2023
Business Services

Cambridge, UK, 27 February 2023: CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems …

Five Alarm Bio, Focused on Minimising the Effects of Aging in Humans, Raises Seed Investment

February 27, 2023
Business Services

Cambridge, UK, 27 February 2023: Five Alarm Bio (FAB), a drug discovery company focused on novel approaches to anti-aging, announced …

FDA sued by US states over abortion pill access

February 27, 2023
Medical Communications

Attorneys general (AGs) from 12 Democrat-led US states have made complaints to the FDA in an attempt to force the …

Causeway Therapeutics raises ยฃ8.75m for tennis elbow research

February 27, 2023
Medical Communications

University of Glasgow spin-out Causeway Therapeutics has announced that it has raised ยฃ8.75m from investors, which will fund an international …

AbbVie gains positive CHMP opinion for upadacitinib for the treatment of Crohnโ€™s disease

February 27, 2023
Medical Communications

AbbVie has announced that it has received positive feedback from the EMAโ€™s Committee for Medicinal Products for Human Use (CHMP) …

Merck to appeal EU rejection of COVID-19 drug

February 27, 2023
Medical Communications

Life science giant Merck & Co has announced that it will appeal the EUโ€™s Committee for Medicinal Products for Human …

Incyte Announces Positive CHMP Opinion for Ruxolitinib Cream (Opzeluraโ„ข) for the Treatment of Non-segmental Vitiligo in Adults and Adolescents

February 24, 2023
Business Services

WILMINGTON, Del. โ€“ February 24, 2023 โ€“ Incyte (Nasdaq:INCY) today announced that the European Medicines Agency (EMA) Committee for Medicinal …

Automata launches the LINQ platform to fully automate workflows and the transport of labware in every lab space

February 24, 2023
Business Services

24th February 2023 โ€“ Automata, a leading automation company powering life science labs to fully automate their workflows, today launches

AviadoBio Signs Exclusive License Agreement with Neurgain Technologies for Novel Gene Therapy Spinal Delivery Technology

February 24, 2023
Business Services

LONDON–(BUSINESS WIRE)–AviadoBio, a pioneering gene therapy company developing and delivering transformative medicines for neurodegenerative disorders and Neurgain Technologies, Inc., an …

Sanofi and Glooko partner on โ€˜connected insulinโ€™ tech

February 24, 2023
Medical Communications

Big pharma company Sanofi aims to develop insulin-based therapies that can be connected with glucose monitoring devices, making it easier …

Mologic Incโ€™s COVID-19 rapid antigen self-test receives FDA Emergency Use Authorization for home use

February 24, 2023
Medical Communications

US subsidiary of Global Access Diagnostics (GADx) โ€’ a developer of lateral flow and rapid diagnostic technologies, products and services …

NICE approved BMSโ€™s Opdivo for lung cancer

February 24, 2023
Medical Communications

Bristol-Myers Squibbโ€™s (BMS) immunotherapy drug Opdivo (nivolumab) has become the first to be cleared for NHS use alongside chemotherapy as …

Moda Living and LloydsPharmacy partner to offer residents prescription service

February 24, 2023
Medical Communications

Moda Living has announced a partnership with LloydsPharmacy to bring residents a โ€˜Health Concierge Serviceโ€™ through VideoGP.   VideoGP will …

The Gateway to Local Adoption Series

Latest content